Kallikrein 8 anticorps (AA 87-241)

N° du produit ABIN7157221

Détail du produit anti-Kallikrein 8 anticorps

Antigène: Kallikrein 8 (KLK8)

Épitope: AA 87-241

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Kallikrein 8 est non-conjugé

Application: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Kallikrein-8 protein (87-241AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur Kallikrein 8

Antigène: Kallikrein 8 (KLK8)

Autre désignation: KLK8 (KLK8 Produits)

Synonymes: anticorps HNP, anticorps NP, anticorps NRPN, anticorps PRSS19, anticorps TADG14, anticorps bsp1, anticorps KLK8, anticorps BSP1, anticorps Nrpn, anticorps Prss19, anticorps kallikrein related peptidase 8, anticorps kallikrein related-peptidase 8, anticorps KLK8, anticorps Klk8

Sujet:

Background: Serine protease which is capable of degrading a number of proteins such as casein, fibrinogen, kininogen, fibronectin and collagen type IV. Also cleaves L1CAM in response to increased neural activity. Induces neurite outgrowth and fasciculation of cultured hippocampal neurons. Plays a role in the formation and maturation of orphan and small synaptic boutons in the Schaffer-collateral pathway, regulates Schaffer-collateral long-term potentiation in the hippocampus and is required for memory acquisition and synaptic plasticity. Involved in skin desquamation and keratinocyte proliferation. Plays a role in the secondary phase of pathogenesis following spinal cord injury.

Aliases: Brain serine protease 1 antibody, BSP1 antibody, hK8 antibody, HNP antibody, HPN antibody, Kallikrein 8 (neuropsin/ovasin) antibody, Kallikrein related peptidase 8 antibody, Kallikrein-8 antibody, Kallikrein8 antibody, KLK 8 antibody, Klk8 antibody, KLK8 protein type 1 antibody, KLK8 protein type 2 antibody, KLK8_HUMAN antibody, Neuropsin antibody, neuropsin type 1 antibody, Neuropsin type 1, included antibody, Neuropsin type 2 antibody, Neuropsin type 2, included antibody, Neuropsin, mouse, homolog of antibody, NP antibody, NRPN antibody, Ovasin antibody, PRO322 antibody, Protease serine 19 antibody, PRSS 19 antibody, PRSS19 antibody, Serine protease 19 antibody, Serine protease kallikrein antibody, Serine protease kallikrein/ovasin/neuropsin antibody, Serine protease TADG 14 antibody, Serine protease TADG-14 antibody, Serine protease TADG14 antibody, TADG 14 antibody, TADG14 antibody, Tumor associated differentially expressed gene 14 antibody, Tumor associated differentially expressed gene 14 protein antibody, Tumor-associated differentially expressed gene 14 protein antibody, UNQ283 antibody

UniProt: O60259

Pathways: Système du Complément